Safety and Tolerability of Physcion in Healthy Volunteers in a Phase I Dose Escalating Clinical Pharmacology Study

被引：0
|
作者：
Tzeng, Tsang-Bin
Chang, Wei-Kuo
Huang, Tien-Yu
Wu, Pei-Tzu
Huang, Wen-Chuan
Lee, Catherine
Wu, Hsing-Hua
Lai, Henry
Chang, Yi-Wei
Lee, Ming-Chung
Kung, Li-Pin
Friedman, Hylar
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [41] Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial
    Qiang Zhou
    Zhiqiang Wang
    Heming Wang
    Zhidong Chen
    Xiaoyi Li
    Xiangrong Dai
    Yong Zhang
    Xiaohui Yu
    Renpeng Zhou
    Wei Hu
    American Journal of Cardiovascular Drugs, 2023, 23 : 101 - 112
  • [42] Safety evaluation of Elixir paregorico® in healthy volunteers: a phase I study
    de Moraes, M. E. A.
    Bezerra, M. M.
    Bezerra, F. A. F.
    de Moraes, R. A.
    Cavalcanti, P. P.
    Uchoa, C. R. A.
    Lima, F. A. V.
    de Moraes, M. Odorico
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2008, 27 (10) : 751 - 756
  • [43] Safety and tolerability following single dose of ONO-9054 in healthy volunteers
    Rowe-Rendleman, Cheryl
    Ouchi, Takafumi
    Ross, Douglas
    Wood, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [44] Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers
    Stypinski, Daria
    Obaidi, Mohammad
    Combs, Michelle
    Weber, Meg
    Stewart, Adrian J.
    Ishikawa, Hiroaki
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (04) : 459 - 468
  • [45] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Qian Zhao
    Hongzhong Liu
    Zhenlei Wang
    Teng Wang
    Cheng Cui
    Huanhuan Wang
    Lili Li
    Wen Zhong
    Ji Jiang
    Kai Dong
    Shuai Chen
    Chunyan Jin
    Pei Hu
    Advances in Therapy, 2023, 40 : 3186 - 3198
  • [46] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
  • [47] Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers:: a dose escalation study
    Horwitz, MJ
    Tedesco, MB
    Sereika, SM
    Garcia-Ocaña, A
    Bisello, A
    Hollis, BW
    Gundberg, C
    Stewart, AF
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (02) : 225 - 230
  • [48] A PHASE I STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF SUBLINGUALLY ADMINISTERED ASENAPINE IN HEALTHY MALE VOLUNTEERS
    Dogterom, P.
    Timmer, C.
    de Greef, R.
    Spaans, E.
    de Vries, D.
    Peeters, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S86 - S87
  • [49] Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers
    Yap, Desmond Y. H.
    Hai, Jojo
    Lee, Paul C. H.
    Zhou, Xueying
    Lee, Michael
    Zhang, Yu
    Wang, Meng
    Chen, Xiaoxiang
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (05): : 1769 - 1779
  • [50] Multiple rising doses of oral BI 1358894 in healthy male volunteers: a phase I study investigating safety, tolerability and pharmacokinetics
    Goettel, M.
    Fuertig, R.
    Wiebe, S.
    Herich, L.
    Sharma, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S254 - S255
12345